Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Bioceres Crop SolutionsBIOX -6.38%60 Equity-to-Asset is 0.14 as of Jun. 2026, which is 55% below its 10-year median of 0.31. GuruFocus rates BIOX with a GF Score™ of 60/100 and a GF Value™ of $4.79 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 258 Agriculture companies, Bioceres Crop Solutions ranks worse than 94.19% on this metric.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Bioceres Crop Solutions Equity-to-Asset Related Terms
Bioceres Crop Solutions Equity-to-Asset Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BIOX vs GNVR, SEED, PUBC: Equity-to-Asset Comparison
For the Agricultural Inputs subindustry, Bioceres Crop Solutions's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bioceres Crop Solutions Equity-to-Asset vs Agriculture Industry
For the Agriculture industry and Basic Materials sector, Bioceres Crop Solutions's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Bioceres Crop Solutions's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Bioceres Crop Solutions's Equity to Asset Ratio for the fiscal year that ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bioceres Crop Solutions (BIOX) has a Equity-to-Asset of 0.14 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bioceres Crop Solutions and its competitors. This is 55% below median its historical median of 0.31. Over the past decade, Bioceres Crop Solutions' Equity-to-Asset has ranged from 0.13 to 1.00. According to the industry distribution chart, Bioceres Crop Solutions ranks #243 out of 258 companies in the Agriculture industry, placing it in the top 94.2%.
Is Bioceres Crop Solutions' Equity-to-Asset too high?
Bioceres Crop Solutions' current Equity-to-Asset of 0.14 is 55% below median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.13 to a high of 1.00. The Agriculture industry median Equity-to-Asset is 0.53. Bioceres Crop Solutions' value of 0.14 is 73.6% below this industry median. Based on the distribution chart, Bioceres Crop Solutions ranks #243 out of 258 companies in the Agriculture industry, which is in the bottom quartile relative to peers. Overall, Bioceres Crop Solutions has a GF Score™ of 60/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Bioceres Crop Solutions' Equity-to-Asset compare to GNVR and SEED?
According to the Agriculture industry distribution chart, Bioceres Crop Solutions ranks #243 out of 258 companies for Equity-to-Asset. This places Bioceres Crop Solutions in the lower half of its industry. The industry median Equity-to-Asset is 0.53. Bioceres Crop Solutions' value of 0.14 is 73.6% below this benchmark. Historically, Bioceres Crop Solutions' own Equity-to-Asset has ranged from 0.13 to 1.00 over the past decade. While the company's 10-year median is 0.31 vs. the industry median of 0.53, Bioceres Crop Solutions has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for an Agriculture company?
The median Equity-to-Asset among Agriculture companies is 0.53, based on 258 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bioceres Crop Solutions's current Equity-to-Asset of 0.14 is 73.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Bioceres Crop Solutions and its competitors. For the Agriculture industry, the median Equity-to-Asset is 0.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bioceres Crop Solutions's current Equity-to-Asset is 0.14, which is 55% below median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bioceres Crop Solutions stock overvalued right now?
Based on GuruFocus' analysis, Bioceres Crop Solutions (BIOX) is currently considered Possible Value Trap. The stock's GF Value™ is $4.79, compared to a current price of $0.34 — trading 93% below its estimated fair value. The current Equity-to-Asset is 0.14, which is 55% below median its 10-year median of 0.31 and 73.6% below the Agriculture industry median of 0.53. Bioceres Crop Solutions' overall GF Score™ is 60/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Bioceres Crop Solutions (BIOX), the current Equity-to-Asset is 0.14 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bioceres Crop Solutions (BIOX) Overvalued in 2026?
Based on GuruFocus' analysis, Bioceres Crop Solutions stock appears to be undervalued.
The current stock price of $0.34 is trading 93% below its estimated GF Value™ of $4.79.
GuruFocus considers Bioceres Crop Solutions to be Possible Value Trap.
Key valuation signals for BIOX:
Equity-to-Asset: 0.14 (55% below median its 10-year median of 0.31)
GF Value™: $4.79 vs. price of $0.34 (93% below fair value)
Industry Position: 73.6% below the Agriculture median (#243 of 258)
No single metric tells the full story. See the BIOX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bioceres Crop Solutions Corp is a fully integrated provider of crop productivity solutions, including seeds, seed traits, seed treatments, biologicals, high-value adjuvants, and fertilizers. The company has developed a multi-discipline and multi-product platform capable of providing solutions throughout the entire crop cycle, from pre-planting to transportation and storage. Some of the products offered by the company include fertilizers, inoculants, adjuvants, crop protection solutions, and seeds among others. Its operating segments are crop protection, which derives key revenue, seed and integrated products, and crop nutrition. Geographically, the majority of the company's revenue is generated from Argentina and the rest from Brazil, North America, Latin America, and other regions.
60GF Score
Get the complete analysis for BIOX
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BIOX has been successfully added to your 
